HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ME3738 protects from concanavalin A-induced liver failure via an IL-6-dependent mechanism.

Abstract
ME3738 is a new compound that attenuates liver disease in several models of acute and chronic liver inflammation. We used the concanavalin A (Con A) model to elucidate the molecular mechanisms of ME3738 to block liver cell damage. Pretreatment of BALB/c mice with ME3738 prior to Con A injection resulted in a significant reduction in liver injury. The protective effect of ME3738 prior to Con A injection was associated with a reduction in IL-6 serum levels and NF-kappaB DNA binding in liver nuclear extracts. However, STAT3 DNA binding was induced via ME3738 prior to Con A injection. Further analysis showed that ME3738 induces IL-6 serum levels and activates STAT3 DNA binding and target gene transcription. The relevance of this finding was assessed in IL-6(-/-) mice. In these animals, ME3738 induced no increase in IL-6 serum expression, and activation of IL-6-dependent pathways was not found. In addition, ME3738 did not protect IL-6(-/-) animals from Con A-induced liver failure, while IL-6 injection was still effective. Therefore, we demonstrate that ME3738 triggers IL-6 expression, which activates pathways that are relevant to protect from Con A-induced liver failure.
AuthorsChristian Klein, Torsten Wüstefeld, Peter C Heinrich, Konrad L Streetz, Michael P Manns, Christian Trautwein
JournalEuropean journal of immunology (Eur J Immunol) Vol. 33 Issue 8 Pg. 2251-61 (Aug 2003) ISSN: 0014-2980 [Print] Germany
PMID12884300 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • Immunosuppressive Agents
  • Interleukin-6
  • ME3738
  • NF-kappa B
  • STAT3 Transcription Factor
  • Stat3 protein, mouse
  • Trans-Activators
  • Tumor Necrosis Factor-alpha
  • Concanavalin A
  • soyasapogenol A
  • Oleanolic Acid
Topics
  • Acute-Phase Reaction (genetics, immunology)
  • Animals
  • Concanavalin A (toxicity)
  • DNA-Binding Proteins (metabolism)
  • Gene Expression (drug effects)
  • Immunosuppressive Agents (chemistry, pharmacology)
  • Interleukin-6 (deficiency, genetics, metabolism)
  • Liver Failure (chemically induced, immunology, pathology, prevention & control)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • NF-kappa B (metabolism)
  • Oleanolic Acid (analogs & derivatives, chemistry, pharmacology)
  • STAT3 Transcription Factor
  • Trans-Activators (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: